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Background: Although, glucocorticoid (GC) and calcitonin-induced changes in bone repair have been studied
previously, the exact effects of these on fracture healing remain controversial. Hence, the purpose of this
experimental study is to determine biochemical and histological effects of locally administrated GC and systemically
administrated calcitonin on the kinetics of healing response after bone marrow ablation in rats.
Methods: After having undergone marrow ablation, a steroid-treated group of rats (n = 24) received a single dose
of intramedullary methylprednisolone (2 mg/kg), a calcitonin-treated group (n = 24) received intermittently
administrated subcutaneous salmon calcitonin (16 IU/kg), and a control group (n = 24) received intramedullary
saline (25 μl).
Results: Blood samples taken on days 1, 3, 7, 9, and 15 after ablation showed an increase in serum calcium, alkaline
phosphatase (ALP), and phosphate levels in the Calcitonin and Control groups. Levels of calcium and ALP peaked
on day 7 after ablation. However, an increase in phosphate levels indicated a biphasic reaction that peaked on the
third and ninth day after ablation. Hypercalcemia was not observed in Steroid group because of the inhibition of
osteoclastic bone resorption. In that group, the serum levels of ALP and phosphate were lower than baseline levels.
The levels of urinary calcium excretion peaked 3 to 7 days after marrow ablation in the control group and 7 to
9 days after that procedure in the steroid group. Histologic evaluation showed that the rats in the control group
demonstrated the expected healing period according to the histological grades and that a delay in healing
occurred in the calcitonin group after day 9 because of the inhibition of osteoclastic bone resorption. All rats in the
steroid group exhibited a decrease and delayed healing response.
Conclusion: Total serum calcium, phosphate, and ALP levels increased after bilateral tibial bone marrow ablation
and urine calcium and hydroxyproline excretion also increased as a factor of bone resorption. Subcutaneously
administrated salmon calcitonin did not affect biochemical changes after marrow ablation. Single-dose
intramedullary methylprednisolone inhibited extra-tibial bone resorption induced by cytokines after bone marrow
ablation.
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Mechanical bone marrow ablation (BMX) is a conveni-
ent model of intramembranous bone regeneration, in
which the intramedullary bone formation occurring on
postoperative days 1 to 8 is followed by the resorption of
that bone and the re-establishment of red marrow tissue
on postoperative days 9 to 15 (Gazit et al. 1989; Gazit
et al. 1990; Liang et al. 1992; Magnuson et al. 1997;
Schwartz et al. 1989; Suva et al. 1993). BMX, even that
which occurs in 1 limb, promotes osteogenesis and
chondrogenesis in distant skeletal sites without a re-
spective stimulation of hard tissue resorption (Muhlrad
et al. 1981; Gazit et al. 1990).
Although, glucocorticoid (GC) and calcitonin-induced
changes in bone metabolism have been studies previ-
ously in the literature, the exact effects of these on frac-
ture healing and resorption remain controversial due to
different methodologies, heterogenous study groups, dif-
ferent outcome measures and non-comparative conclu-
sions. It is very well-known in the literature that long-
term treatment with GCs leads to osteoporosis caused
by the inhibition of bone formation and the stimulation
of bone resorption (Hardy et al. 1993; He et al. 2016;
Hellewell et al. 1974; Kang et al. 2016; Shi et al. 2015;
Wang et al. 2002). The change in bone formation may
be a direct effect of steroid treatment, but the increased
osteolysis probably results from secondary hyperpara-
thyroidism that is caused in turn by decreased intestinal
calcium absorption and increased urinary calcium excre-
tion (Hardy et al. 1993; Suzuki et al. 1983; Yan et al.
2012; Wang et al. 2002). Calcitonin, has also been evalu-
ated in the literature in a wide array and approved for
the prevention and treatment of osteoporosis (Li et al.
1996). Results from clinical trials and animal studies
have shown that calcitonin inhibits bone turnover and
prevents bone loss in early postmenopausal woman
Gennari et al. 1992; Reginster et al. 1994; Rizolli et al.
2015), and in ovariectomized rats (Bonucci et al. 1995;
Li et al. 1996; Wei et al. 2015; de Vernejoul et al., 1990).
It has also been shown to modestly increase bone mass
in patients with established osteoporosis (Bonucci et al.
1995; Gennari et al. 1992; Reginster et al. 1994; de Ver-
nejoul et al. 1990). In the literature, calcitonin is most
widely applied intermittently by subcutaneous injection,
nasal spray, rectal suppository, or vaginal deposition.
However, the effects of the continuous administration of
calcitonin have received little attention to date (Li et al.
1996). To our knowledge, this is one of first studies in
the literature that analyzes the biochemical and histo-
logic effects of both intramedullary GC and subcutane-
ous continuous calcitonin application on bone repair
process in a comparative animal model of BMX.
Hence, the purpose of this experimental study is to de-
termine the biochemical and histologic effects of locallyadministrated GC and systemically administrated calci-
tonin on the kinetics of bone healing process via quanti-
tative biochemical blood markers and microscopic
analysis and to compare the results in order to deter-
mine the exact effects of these hormones.
Methods
Study groups
Seventy-two male Sprague–Dawley rats (weight range,
250–290 g) were used for the experimental animal
model. The animals were treated ethically in compliance
with regulations of Uludag University School of Medi-
cine, Bursa, Turkey, whose quite for the use of experi-
mental animals is based on the principles of laboratory
animal care from NIH.
Three study groups (24 rats apiece) were created after
right tibial BMX was applied to all 72 rats:
1. Rats with intramedullary GC application (Steroid
group)
2. Rats with subcutaneous continuous salmo calcitonin
application (Calcitonin group)
3. Rats with subcutaneous continuous sterile saline
application (Control group)
Five rats from each group were randomly selected at
first, third seventh and ninth day after surgeries (a total
of 20 rats for each group) and all were killed with an
overdose of sodium pentobarbital. The remaining 4 rats
at each group were killed in the same manner 15 days
after surgery. The blood samples were obtained by heart
puncture. Immediately after the rats had been killed, the
right tibia from each animal was placed in cold 70%
ethanol and processed for histological evaluation.
BMX and surgical procedures
All rats were anesthetized by the intraperitoneal admin-
istration of ketamine hydrochloride (80 mg/kg) and of
xylazine (12 mg/kg). BMX was performed on both tibias
of each rat according to the method described by Suva
et al. After the proximal region of each tibia had been
exposed, a 1.5 to 2.0-mm hole was drilled in the cortex
below the proximal metaphysis, and the marrow was re-
moved via several rounds of suction and flushing with
sterile saline.
Twenty-five micro liters (μl) of methylprednisolone so-
dium succinate (2 mg/kg) in sterile saline solution was
injected into the intramedullary cavity in the steroid
group immediately before wound closure.
Subcutaneous salmon calcitonin application (16 IU/kg)
was begun at the first postoperative day and continu-
ously applied per day till the day of sacrifization for each
rat in Calcitonin group (Li et al. 1996). Similarly, 25 μl
of sterile saline solution was applied to the rats in the
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cedures, each rat was housed alone in a standard cage,
and food and water access was held unrestricted.
Blood and urine sample analysis
Blood samples were collected and stored at −40 °C until
use. The levels of serum calcium, alkaline phosphatase
(ALP), and phosphate were measured in each blood
sample. Calcium and phosphorous concentrations were
determined by cresolphthalein complexone method and
the phosphomolybdate method, respectively. Alkaline
phosphatase activity was determined using p-nitrophenol
phosphate as substrate. An automated analyzer (Parallel,
American Monitor Corp., Indianapolis, IN) was used for
all these assays. Four rats from each experimental group
were maintained individually in metabolic cages for
15 days after surgery, and daily urine specimens were
frozen for the urine sample analysis. The first urine sam-
ple which was collected during the 24 h-period before
BMX was referred as day zero. Levels of urine calcium,
creatinin, and deoxypyridinoline (Dpd) were analyzed
with an immunoassay method which specifically marks
monoclonal anti-Dpd antibody-anticore (IMMULITE
Pyrilinks-D, EURO-DPC Ltd., Glyn Rhonwy Llanberis,
Gwynedd, United Kingdom).
Histologic analysis
Immediately after the animals were killed, the samples
from right tibias were fixed for 2 to 3 days in 10% neutral
buffered formalin, followed by a 2-day period of
immersion in Bouin’s solution and were then decalcified
in 10% acetic acid, 0.85% NaCl, and 10% formalin. The
specimens were then embedded in paraffin, sectionedTable 1 Results of serum calcium, phosphate and ALP values after B
Days after BMX
1
(n = 5)
3
(n = 5)
7
(n =
Blood Calcium level (mg/dl)
Control group 9.65 ± 1.22 9.47 ± 2.35 12.4
Calcitonin group 9.23 ± 1.47 9.80 ± 1.61 11.2
Steroid group 9.59 ± 1.33 9.33 ± 0.46 8.96
Blood Phosphate level (mg/dl)
Control group 5.13 ± 1.75 7.96 ± 0.30 b 6.39
Calcitonin group 4.37 ± 0.97 8.98 ± 1.55 b 7.83
Steroid group 5.04 ± 1.56 4.74 ± 0.81 4.93
Blood ALP level (IU/L)
Control group 172.3 ±. 11.0 191.7 ± 41.4 a 206.
Calcitonin group 128.3 ± 14.7 218.0 ± 86.9 a 267.
Steroid group 157.0 ± 24.7 115.3 ± 27.3 120.
All values are expressed as mean ± S.D. ALP: alkaline phosphatase
a p < 0.05, b p < 0.01, significantly different from steroid grouplongitudinally, and stained with hematoxylin and eosin to
assess morphological progression of tissue regeneration
within the bone marrow cavity. The progression of mar-
row healing in each specimen was quantified by means of
a scale that assigns a grade according to the relative per-
centage of necrosis, osteoblast, osteoclast, woven bone,
and mature bone (Suva et al. 1993). The cell type identifi-
cation was performed by the morphological features of
the specific cell types stained with hematoxylin and eosin
under light microscopy. In this 5-step grading system,
Grade 1through 5 indicates hemorrhage and necrosis
(postsurgical day 1); mesenchymal cell proliferation (day
3); an increase in the number of osteoblasts and the first
appearance of woven bone (day 7); a decrease in the num-
ber of osteoblasts and transformation to woven bone (day
9); and the presence of both woven bone and mature bone
(day 15), respectively.
Statistical analysis
Comparison data from all samples were obtained via
one-way analysis of variance (ANOVA). All tests were
controlled with Bonferroni correction. Statistical differ-
ences were defined at a confidence level of 95%. The
statistical values were given as the mean ± SD. SPSS
(Statistical Package for the Social Sciences, version 10.0;
SPSS, Inc., Chicago, III, USA) software supported the
statistical evaluation. Statistical significance was deter-
mined as p<. 05 (two-tailed).
Results
Blood sample analysis
Table 1 summarizes the mean blood concentrations of
the study groups for calcium, phosphate and ALP.MX
5)
9
(n = 5)
15
(n = 4)
p (ANOVA)
3 ± 1.69a 9.85 ± 1.88 9.66 ± 1.89 NS
9 ± 0.93 a 9.75 ± 1.17 9.37 ± 1.22 NS
± 1.48 9.36 ± 0.71 10.01 ± 2.58 NS
± 1.24 10.33 ± 2.89 b 4.36 ± 1.52 .016
± 1.67 9.39 ± 1.46 a 5.30 ± 1.15 .042
± 1.64 5.25 ± 0.96 6.65 ± 1.48 NS
7 ± 16.0 a 164.5 ± 21.8 154.3 ± 33.0 .038
3 ± 29.5 a 256.7 ± 45.5 a 176.0 ± 71.6 .004
8 ± 32.5 133.3 ± 5.6 200.2 ± 64.3 .009
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The level of the total serum calcium concentration dra-
matically increased within 7 days after BMX surgery in
the control and calcitonin groups. The average serum
calcium values 7 days after surgery for the Control and
Calcitonin groups were 12.43 ± 1.69 mg/dl and
11.29 ± 0.93 mg/dl, respectively. In contrast, no hyper-
calcemia was detected in the Steroid group during the
follow-up period of 15 days. In the steroid group, total
serum calcium values decreased to a minimum of
8.96 ± 0.48 mg/dl 1 week after surgery. There was statis-
tically significant difference between the Steroid group
and the other study groups (p<. 05 Steroid vs. Control
and Calcitonin groups) (Table 1).
Phosphate
In Control and Calcitonin groups, the total serum phos-
phate levels begun to increase on the first day after BMX
and reached the maximum level of xxxx on the third and
ninth day. The phosphate level for these study groups
turned to normal 15 days after surgery. There was no sta-
tistically significant difference between Control and Calci-
tonin groups (p=. 016, Control group; p=. 042, Calcitonin
group). The serum phosphate level decreased significantly
after BMX in the Steroid group compared with the other
groups 3 days after surgery (p<. 01 Steroid vs. Control and
Calcitonin groups) (Table 1).
Alp
In the Control group, total serum ALP levels increased
slowly starting from the first day (172.3 ± 11.0 IU/L)Table 2 Results of urine calcium, Dpd, and creatinin values after BM
Days after BMX
Day 0
(n = 8)
1
(n = 8)
3
(n = 8)
Urine Calcium level (mg/dl/24 h)
Control group 6.42 ± 1.73 6.91 ± 1.57 15.61 ± 2.97 ce†
Calcitonin group 6.42 ± 1.73 6.84 ± 2.44 6.27 ± 1.82
Steroid group 6.42 ± 1.73 6.81 ± 3.58 6.83 ± 3.56
Urine Dpd level (μg/day)
Control group 126.4 ± 28.6 69.2 ± 16.4 117.0 ± 36.5 f
Calcitonin group 126.4 ± 28.6 51.8 ± 13.3 107.6 ± 16.8 e
Steroid group 126.4 ± 28.6 48.9 ± 9.4 72.9 ± 7.6
Urine Cr eatinin level (mg/day)
Control group 122.3 ± 12.5 139.3 ± 44.5 102.9 ± 38.4 e
Calcitonin group 122.3 ± 12.5 143.0 ± 44.1 131.2 ± 55.3
Steroid group 122.3 ± 12.5 141.8 ± 27.9 175.8 ± 45.8
All values are expressed as mean ± S.D. Dpd: deoxypyridinoline
a p < 0.05, b p < 0.01,significantly different from control group
c p < 0.05, d p < 0.01, significantly different from calcitonin group
e p < 0.05, f p < 0.01, significantly different from steroid group
† p < 0.05, ‡ p < 0.01 significantly different from day 0after BMX and reached the maximum level of
206.7 ± 16.0 IU/L on the seventh day. In the Calcitonin
group, the mean value for ALP was 128.3 ± 14.7 IU/L
on the first day after BMX and it increased to
267.3 ± 29.5 IU/L on the seventh day. This increase of
ALP for both study groups was found statistically signifi-
cant (p<. 05 for both). In the Steroid group, ALP levels
decreased on the third and seventh day after BMX sur-
gery (115.3 ± 27.3 IU/L and 120.8 ± 32.5 IU/L, respect-
ively). The ALP levels of the Steroid group was found
significantly different compared with the Control and
Calcitonin groups (p<. 05 Steroid vs. Control and Calci-
tonin groups) (Table 1).
Urinary analysis
Dpd
The level of urinary Dpd in the Control group decreased
on the first day after BMX and then started to increase
from the day 7 and reached the maximum level on the
ninth day (p<. 01, compared with the levels on days 0, 1,
3, and day 15). Nevertheless, urinary Dpd levels sharply
decreased again on the fifteenth day after BMX (Table 2).
The urinary Dpd levels of the Calcitonin group were
similar to that of the control group, but the maximum
urinary excretion occurred on day 15. Dpd levels of the
Calcitonin group was significantly different compared
with the other study groups (p<. 05 vs. steroid group,
and p<. 01, vs. control group).
In the Steroid group, the urinary Dpd values slowly in-
creased on the third day and the lowest value was noted
on day 7. The urinary Dpd excretion then started toX
p (ANOVA)
7
(n = 8)
9
(n = 8)
15
(n = 4)
23.74 ± 7.91 ‡ 8.74 ± 2.91 9.45 ± 2.78 < .0001
9.14 ± 3.28 ae 8.40 ± 2.14 7.85 ± 1.92 NS
20.08 ± 7.14 † 31.47 ± 6.35 bd‡ 19.41 ± 8.42† < .0001
159.6 ± 42.6 cf 227.3 ± 84.4 df† 72.4 ± 16.8 .0026
89.4 ± 24.3 f 91.5 ± 17.9 138.7 ± 14.6 be .0081
32.9 ± 13.5 ‡ 72.4 ± 26.4 92.5 ± 22.8 .0013
82.3 ± 31.5 e 80.0 ± 45.3 82.6 ± 56.5 .017
118.2 ± 34.1 132.6 ± 70.8 102.5 ± 27.3 NS
175.1 ± 88.8 94.2 ± 38.4 99.5 ± 22.1 .005
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levels of the Steroid group was significantly different
compared with the other study groups (p<. 01 for both
groups).Calcium
Urinary calcium excretion in the Control group in-
creased nearly 4-fold over pre-ablation level 7 days after
BMX. This increase was not statistically significant (p=.
0021, day 7 vs. day zero). In the Calcitonin group, the
urinary calcium excretion level did not significantly
change in this 15-day study period (p > .05). Urinary cal-
cium excretion also increased after BMX in the Steroid
group; however, the maximum increase occurred 9 days
after BMX. On contrary to Control group, this increase
was found statistically significant (p=. 004, day 9 vs. day
zero). (Table 2).Histologic analysis
Control group
The histological sections are randomized and evaluated
in a blinded assessment by 2 pathologists specified in
musculoskeletal problems. Within the first several hours
after ablation in the Control group, the formation of a
large clot was identified within the marrow cavity (Fig.
1a). Three days after ablation, a cellular structure had
formed by a large number of mesenchymal cells. On day
7, the medullar space was densely lined with osteoblasts
and small amount of new bone formation was noted at
those sites. After that period, most of the surface of the
intramembranous space contained osteoclasts, which
were resorbing the new cancellous bone. Osteoblasts
that covered the newly formed woven bone also ap-
peared and occupied the excavation marrow space on
days 9 and 10. On day 15, the marrow cavity in the Con-
trol group contained woven bone and trabecular bone
(Figure 1b). Histologic analysis of Control group revealed
an expected healing period according to the histological
grades.Fig. 1 Hematoxylin- and eosin-stained histological sections of Control group.
b After 15 days, the marrow cavity was filled with woven bone and trabeculaCalcitonin group
Contrary to the all BMX applied specimens with a
complete medullary ablation histologically, mature bone
and bone marrow were detected in one of the specimens
of the Calcitonin group on day 3. After that specimen
had been reanalyzed, it was concluded that the medul-
lary ablation was only retained as a small focal injury,
not enough to accept as a complete BMX. The other
areas of bone marrow seemed to be healthy. Because of
this inappropriate BMX, that sample was excluded from
the study group.
On day 7 after ablation, the healing process was found
to be faster than anticipated. In those samples, grade 4
healing (highly trabecular bony areas) and grade 5 (tra-
becular bone and bone marrow development) were noted
instead of grade 3 (massive osteoblasts and new bone for-
mation) (Fig. 2a). There was a delay in the healing process
in 2 of the 4 samples taken on day 15. In those 2 samples,
although trabecular bone and mature bone marrow devel-
opment (grade 5) was expected, massive osteoblasts and
new bone formation (grade 3) was detected (Fig. 2b). The
non-developed bone marrow was accepted as a sign of
delay in healing for 5 to 6 days.
Steroid group
Histologic analyses of the Steroid group showed that tibial
healing was delayed and tissue repair occurred less quickly
than expected for all samples. Although significant num-
bers of mesenchymal cells were expected on the third day
after BMX (grade 2 healing), the samples taken on the
third day had only bleeding and necrosis (grade 1 healing)
revealing a delay in bone repair (Fig. 3a). Similarly,
samples taken on day 9 after BMX also showed a de-
layed bone healing with microscopic features of sam-
ples taken on days 5 to 7, which demonstrated large
numbers of mesenchymal cells and osteoblasts. In all
4 samples taken on day 15, newly developed trabecu-
lar bone (grade 4 healing) was detected (Fig. 3b) in-
stead of mature bone marrow (grade 5 healing), again
revealing a delay in bone repair process.a A large blood clot was revealed within the within the first hours (X40).
r bone (X200)
Fig. 2 Hematoxylin- and eosin-stained histological sections of Calcitonin group. a After a week, the healing process was faster than expected.
Trabecular bone and bone marrow development (grade 5) were noted instead of massive osteoblasts and new bone formation (grade 3) (X40).
b There was a delay in healing on day 15, which was detected by massive osteoblasts and woven bone (X100)
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This is one of the first studies in the literature which
compares the biochemical and histopathological effects
of intramedullary GC and continuous subcutaneous sal-
mon calcitonin application on bone repair after BMX.
The main finding of this study is that although subcuta-
neously administrated salmon calcitonin has no affect
on biochemical changes after marrow ablation, single-
dose intramedullary methylprednisolone inhibits extra-
tibial bone resorption induced by cytokines.
In the literature, there are dozens of studies analyzing
the different aspects of bone repair process. In order to
understand this process, BMX has been generally accepted
as a reliable methodology. Because of its fast healing
process, which is independent from the bone cortex,
BMXs in rats is widely used as an animal model for intra
membranous fracture repair (Magnuson et al. 1997). In
rats, the removal of tibial marrow induces primary
mineralization in endosteal bone formation, devoid of car-
tilaginous phase (Chisin et al. 1988; Kuroda et al. 2005).
BMX effectively induces the repair-resorption phase of
healing (Gazit et al. 1989; Kuroda et al. 2005; Schwartz
et al. 1989; Suva et al. 1993), and it is possible to measure
the levels of calcium and hydroxyproline in the urine and
blood of the rats studied (Gorski et al. 2000; MagnusonFig. 3 Hematoxylin- and eosin-stained histological sections of Steroid group.
day 3 (X100). b The marrow cavity filled with woven bone instead of trabeculet al. 1997). For these reasons, in our study, we have de-
signed an experimental animal model with BMX in rats
for the in-depth analysis of bone repair process and used a
previously described methodology albeit safe and effective.
In order to analyze the bone repair process after BMX,
there have been various mode of application methods, de-
scribed in the literature for different agents. In these stud-
ies, the intramedullary and intramuscular administration of
GC and subcutaneous administration of SC have been eval-
uated. On contrary to these studies, we have continuously
applied SC till the day of sacrifization for each rat. We be-
lieve that, different mode of administration may have differ-
ent results. So, in the current study we compared the
outcomes of these different administration methods and try
to understand the effects for different agents.
Biochemical changes
Although some studies in the literature have already in-
vestigated the histopathological changes of bone repair,
none of them has analyzed the biochemical parameters
of the repair-resorption phase and the healing-time rela-
tionship (Gorski et al. 2000; Liang et al. 1992; Suva et al.
1993). In a study by Magnuson et al., which analyzed the
changes in biochemical parameters that occurred over-
time, although the outcomes of GC application werea Tibial healing delayed and the bleeding and necrosis were detected on
ar on day 15 (X40). T, trabecular bone; W, woven bone; Ob, osteoblast
Fig. 4 The boxplot graph of biochemical analysis for the study groups in regard to specific time intervals
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Magnuson et al. concluded that the total serum cal-
cium level increased after bilateral tibial BMX and
blocked with the use of a single dose intramedullary
GC administration. Nevertheless, some investigators
reported that a decrease in serum calcium levels oc-
curred within 24 h after BMX (Bagnoli et al. 1984;
Cooper et al. 1989; Meller et al. 1984). Bagnoli et al.
assumed that the decrease in the serum calcium
levels was due to a high level of plasma calcitonin
and the inhibition of osteoclastic resorption. We have
comparable results with the literature in regard to
serum calcium levels. In our study, hypercalcemia wasFig. 5 The boxplot graph of urine analysis for the study groups in regard todetected in the calcitonin group 3 to 7 days after ab-
lation, as it was in the control group (Fig. 4).
Several studies suggest that serum phosphate levels de-
crease immediately after fracture, increase after 24 h, re-
main high, and then slowly decrease again, possibly in
relation to the period of disability (Meller et al. 1985;
Speed 1931). Hardy et al. reported that the decrease in
serum phosphate levels immediately after fracture and the
increase, later, was related to the serum calcium levels. In
our study, we also have found an association between
serum phosphate and calcium levels, but the decrease in
the serum phosphate levels on day 7 could have been due
to the biochemical difference between humans and rats.specific time intervals
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bone formation because of its correlation with calcifica-
tion. Chondroblasts, osteoblasts and odontoblasts, which
are characterized by ALP-specific activity, may control
the initial phase of mineralization via matrix vesicles
which can be found in various normal and pathologic
tissues (Boskey 1981; Schwartz et al. 1989; Wuthier
1982). In a study analyzing the changes of ALP activity
during alveolar bone repair in matrix vesicles, Muhlrad
et al. reported a decrease in the activity of ALP on the
third day of healing and an increase on the ninth day.
The changes in ALP levels as a result of bone repair dif-
fer according to the study models. In an animal model
by Muhlrad et al., granulation tissue formation and new
bone formation (characterized by) (characterized by an
increase in ALP on the ninth day) were evaluated. It was
concluded that although a decrease in ALP on the third
day was due to granulation tissue formation, on the
ninth day, an increase of ALP was seen because of the
new bone formation. In our study, direct endosteal new
bone formation was used as a model and contrary to the
literature, a decrease of ALP level was detected in the
Steroid group. The results of Control and Calcitonin
groups had comparable outcomes with the literature.
Urine analysis
In the literature, several studies claimed that long-term
glucocorticoid usage could have increased calcium excre-
tion in urine as a sign of bone resorption (Hahn et al.
1981; Magnuson et al. 1997). On contrary, Suziki et al. at-
tributed that the reason for increased calcium excretion in
urine was due to the decreased reabsorption from the kid-
neys. In our study, urinary calcium excretion began to in-
crease immediately after BMX and reached its highest
level on day 7 in the Control group. In the steroid group,
urinary calcium excretion began to increase on day 3 after
BMX and reached its highest level on day 9 (Fig. 5). It was
previously indicated in the literature that the increased
urinary calcium levels 3 to 8 days after BMX was a result
of 2 mechanisms: resorption from the extra-tibial skeleton
and resorption from the newly developed bone tissue in
the tibial medullary cavity (Magnuson et al. 1997). In our
study, on contrary to the control group, the excretion of
calcium was delayed 2 to 3 days in the Steroid group, We
believe that this delay was caused by methylprednisolone,
which initially inhibits cytokines and causes decreased
bone resorption in 1 to 7 days before affecting the intes-
tines and the kidneys in 8 to 15 days (Hahn et al. 1981;
Reid & Ibbertson 1987; Suzuki et al. 1983).
Histopathologic evaluation
The literature contains various studies analyzing the effects
of different parameters on the repair process of bone. The
experimental animal models reveal the different stages ofbone repair process and the possible factors that favor or in-
hibit that process. Medullary bone marrow fills the medul-
lary cavity in a 15-day period in marrow ablation model
(Gazit et al. 1990; Magnuson et al. 1997; Suva et al. 1993). In
that model of BMX, the healing process is intramembranous
ossification and the stages of callus formation (fibrous-cartil-
age-bone) that is expected in the other healing models, has
not been seen in this model (Magnuson et al. 1997; Suva
et al. 1993). In our study, a normal healing process was
demonstrated by the histologic analysis of samples from the
Control group. Although the same healing process was ob-
served in the Calcitonin group, we detected a delay in the
healing process after 9 days. This delay may have been a re-
sult of the inhibitory effect of calcitonin on osteoclastic re-
sorption. In the histologic analyses from the Steroid group, a
decreased or delayed healing response was found in 5
(41.6%) of 12 samples, a result supported by other published
studies (Gazit et al. 1989; Gazit et al. 1990; Magnuson et al.
1997; Schwartz et al. 1989; Suva et al. 1993).
Conclusion
We concluded that in our study, total serum calcium,
phosphate, and ALP levels increased after bilateral tibial
BMX and urine calcium and hydroxyproline excretion
also increased as a factor of bone resorption. Subcutane-
ously administrated salmon calcitonin did not affect bio-
chemical changes after BMX but has a negative effect on
histopathological repair process of bone after 9 days of
continuous administration. Single-dose intramedullary
methylprednisolone inhibited extra-tibial bone resorp-
tion induced by cytokines after BMX. So we believe that,
these agents may have a potential to be used clinically in
bone fracture repair in the future for those who have a
high risk for surgical treatment.
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